Abstract
AbstracttRNA is the RNA type that undergoes the most modifications among known RNA, and in recent years, tRNA methylation has emerged as a crucial process in regulating gene translation. Dysregulation of tRNA abundance occurs in cancer cells, along with increased expression and activity of tRNA methyltransferases to raise the level of tRNA modification and stability. This leads to hijacking of translation and synthesis of multiple proteins associated with tumor proliferation, metastasis, invasion, autophagy, chemotherapy resistance, and metabolic reprogramming. In this review, we provide an overview of current research on tRNA methylation in cancer to clarify its involvement in human malignancies and establish a theoretical framework for future therapeutic interventions targeting tRNA methylation processes.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference212 articles.
1. Li J, Zhu WY, Yang WQ, Li CT, Liu RJ. The occurrence order and cross-talk of different tRNA modifications. Sci China Life Sci. 2021;64:1423–36.
2. Kotsiliti E. Targeting hyperactive tRNA modification improves anti-PD1 efficacy. Nat Rev Gastroenterol Hepatol. 2023;20:3.
3. Suzuki T. The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol. 2021;22:375–92.
4. Orellana EA, Liu Q, Yankova E, Pirouz M, De Braekeleer E, Zhang W, et al. METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation. Mol Cell. 2021;81:3323–38.
5. Abedini SS, Kahrizi K, de Pouplana LR, Najmabadi H. TRNA Methyltransferase Defects and Intellectual Disability. Arch Iran Med. 2018;21:478–85.